NCT03438526View on ClinicalTrials.gov

The Basel BOMP-AID Randomized Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Hypoactive Delirium
Interventions
DRUG

Melatonin (Circadin ®)

4 mg of oral melatonin at 8 p.m. for the length of the duration of the hypoactive delirium

DRUG

Placebo

Lactose monohydrate, cellulose powder, magnesium stearate (Ph. Eur.), mocrocristalline cellulose

Trial Locations (1)

4031

RECRUITING

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER